FDA evidence audit: PEG-MGF human exposure
FDA states it has not identified human exposure data for drug products containing PEG-MGF.
What this study tells us
This is a regulator evidence review, not a participant treatment trial. It is useful for showing what human exposure or safety evidence the regulator could — or could not — identify.
No human drug-product exposure identified
Not applicable — this is a regulator evidence review, not a participant trial.
FDA states it has not identified human exposure data for drug products containing PEG-MGF.
Published MGF peptide biology does not establish exposure or efficacy of the PEGylated product.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
FDA states it has not identified human exposure data for drug products containing PEG-MGF.